Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 6c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $32.5 million versus the consensus estimate of $30.58 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c